178 related articles for article (PubMed ID: 2998275)
21. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes.
Trousdale MD; Nesburn AB; Su TL; Lopez C; Watanabe KA; Fox JJ
Antimicrob Agents Chemother; 1983 Jun; 23(6):808-13. PubMed ID: 6311085
[TBL] [Abstract][Full Text] [Related]
22. Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil.
Matulic-Adamic J; Takahashi K; Chou TC; Gadler H; Price RW; Reddy AR; Kalman TI; Watanabe KA
J Med Chem; 1988 Aug; 31(8):1642-7. PubMed ID: 2840503
[TBL] [Abstract][Full Text] [Related]
23. Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines.
Reefschläger J; Herrmann G; Bärwolff D; Schwarz B; Cech D; Langen P
Antiviral Res; 1983 Sep; 3(3):175-87. PubMed ID: 6316849
[TBL] [Abstract][Full Text] [Related]
24. Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy)methyl]guanine in combination with recombinant interferons.
Eppstein DA; Marsh YV
Biochem Biophys Res Commun; 1984 Apr; 120(1):66-73. PubMed ID: 6201172
[TBL] [Abstract][Full Text] [Related]
25. Antiviral effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegalovirus infection in a guinea pig model.
Fong CK; Cohen SD; McCormick S; Hsiung GD
Antiviral Res; 1987 Jan; 7(1):11-23. PubMed ID: 3026243
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiherpes simplex virus activity of 9-[(1,3-dihydroxy-2-propylthio)methyl]guanine.
McGee DP; Martin JC; Smee DF; Matthews TR; Verheyden JP
J Med Chem; 1985 Sep; 28(9):1242-5. PubMed ID: 2993615
[TBL] [Abstract][Full Text] [Related]
27. A quantitative study of the effects of several nucleoside analogues on established herpes encephalitis in mice.
Field HJ; Anderson JR; Efstathiou S
J Gen Virol; 1984 Apr; 65 ( Pt 4)():707-19. PubMed ID: 6323620
[TBL] [Abstract][Full Text] [Related]
28. Acyclic analogues of 2'-deoxynucleosides related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine as potential antiviral agents.
Martin JC; Jeffrey GA; McGee DP; Tippie MA; Smee DF; Matthews TR; Verheyden JP
J Med Chem; 1985 Mar; 28(3):358-62. PubMed ID: 3871860
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
[TBL] [Abstract][Full Text] [Related]
30. Treatment of mucocutaneous herpes simplex infections.
Seidlin M; Straus SE
Clin Dermatol; 1984; 2(2):100-16. PubMed ID: 6085870
[No Abstract] [Full Text] [Related]
31. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells.
Cheng YC; Grill SP; Dutschman GE; Nakayama K; Bastow KF
J Biol Chem; 1983 Oct; 258(20):12460-4. PubMed ID: 6313660
[TBL] [Abstract][Full Text] [Related]
32. A mammalian cell line designed to test the mutagenic activity of anti-herpes nucleosides.
Pizer LI; Mitchell DH; Bentele B; Betz JL
Int J Cancer; 1987 Jul; 40(1):114-21. PubMed ID: 3036717
[TBL] [Abstract][Full Text] [Related]
33. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
34. Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.
Freitas VR; Smee DF; Chernow M; Boehme R; Matthews TR
Antimicrob Agents Chemother; 1985 Aug; 28(2):240-5. PubMed ID: 3010840
[TBL] [Abstract][Full Text] [Related]
35. Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Reefschläger J; Wutzler P; Thiel KD; Herrmann G
Antiviral Res; 1986 Mar; 6(2):83-93. PubMed ID: 3010858
[TBL] [Abstract][Full Text] [Related]
36. Effects of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new antiherpesvirus compound, on synthesis of macromolecules in herpes simplex virus-infected cells.
Cheng YC; Grill SP; Dutschman GE; Frank KB; Chiou JF; Bastow KF; Nakayama K
Antimicrob Agents Chemother; 1984 Sep; 26(3):283-8. PubMed ID: 6095751
[TBL] [Abstract][Full Text] [Related]
37. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
Cheng YC; Huang ES; Lin JC; Mar EC; Pagano JS; Dutschman GE; Grill SP
Proc Natl Acad Sci U S A; 1983 May; 80(9):2767-70. PubMed ID: 6302704
[TBL] [Abstract][Full Text] [Related]
38. Effect of ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)guanine] on viral DNA and protein synthesis in cells infected with herpes simplex virus.
Chun YS; Park NH
Antimicrob Agents Chemother; 1987 Feb; 31(2):349-51. PubMed ID: 3032100
[TBL] [Abstract][Full Text] [Related]
39. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
40. [Isolation of acyclovir-resistant strains of herpes simplex virus from clinical material].
L'vov ND; Andronova VL; Leont'eva NA; Galegov GA
Vopr Virusol; 1999; 44(6):247-9. PubMed ID: 10665057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
